2023 Q2 Form 10-K Financial Statement

#000149315223013524 Filed on April 25, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q4 2022
Revenue $10.00K $10.00K
YoY Change
Cost Of Revenue $800.00 $800.00
YoY Change
Gross Profit $9.200K $9.200K
YoY Change
Gross Profit Margin 92.0% 92.0%
Selling, General & Admin $1.263M $431.4K $1.856M
YoY Change 85.25% 205.4% 234.15%
% of Gross Profit 4688.59% 20170.98%
Research & Development $273.7K $160.9K $609.3K
YoY Change 195.31% 2337.08%
% of Gross Profit 1748.91% 6622.5%
Depreciation & Amortization $430.00 $450.00 $1.045K
YoY Change 168.75%
% of Gross Profit 4.89% 11.36%
Operating Expenses $1.537M $592.2K $2.465M
YoY Change 125.38% 319.31% 343.85%
Operating Profit -$1.537M -$583.0K -$2.456M
YoY Change 125.38% 312.8% 342.2%
Interest Expense $10.84K -$112.5K $347.1K
YoY Change -111.53% 471.54% 759.38%
% of Operating Profit
Other Income/Expense, Net $56.57K $0.00 -$346.7K
YoY Change 94186.67% -100.0% 1037.5%
Pretax Income -$1.480M -$695.5K -$2.802M
YoY Change 90.79% 331.84% 378.37%
Income Tax
% Of Pretax Income
Net Earnings -$1.480M -$695.5K -$2.802M
YoY Change 90.79% 331.84% 378.37%
Net Earnings / Revenue -6955.2% -28024.87%
Basic Earnings Per Share -$0.24 -$0.70
Diluted Earnings Per Share -$0.24 -$0.11 -$0.46
COMMON SHARES
Basic Shares Outstanding 6.087M shares 4.010M shares
Diluted Shares Outstanding 6.056M shares 4.010M shares

Balance Sheet

Concept 2023 Q2 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.460M $57.67K $57.67K
YoY Change 2189.61% 476.12%
Cash & Equivalents $5.460M $57.67K
Short-Term Investments
Other Short-Term Assets $575.6K $15.00K $15.00K
YoY Change 3737.4%
Inventory
Prepaid Expenses $575.6K $15.00K
Receivables
Other Receivables
Total Short-Term Assets $6.035M $72.67K $72.67K
YoY Change 2281.21% 625.68% 625.97%
LONG-TERM ASSETS
Property, Plant & Equipment $6.837K $7.699K $7.700K
YoY Change -20.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $6.837K $7.699K $7.700K
YoY Change -20.31%
TOTAL ASSETS
Total Short-Term Assets $6.035M $72.67K $72.67K
Total Long-Term Assets $6.837K $7.699K $7.700K
Total Assets $6.042M $80.37K $80.37K
YoY Change 2205.85% 702.57% 702.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $490.7K $544.0K $544.0K
YoY Change 384.56% 693.06% 693.1%
Accrued Expenses $195.9K $416.1K $983.0K
YoY Change -71.96% 506.9% 177.51%
Deferred Revenue
YoY Change
Short-Term Debt $423.1K $1.579M $1.579M
YoY Change -68.01% 15687.4% 169.27%
Long-Term Debt Due $423.1K
YoY Change
Total Short-Term Liabilities $1.142M $3.138M $3.138M
YoY Change -47.01% 207.89% 207.89%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.142M $3.138M $3.138M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.142M $3.138M $3.138M
YoY Change -47.01% 207.89% 207.89%
SHAREHOLDERS EQUITY
Retained Earnings -$7.205M -$4.399M
YoY Change 175.53%
Common Stock $61.00 $40.00
YoY Change -13.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.900M -$3.057M -$3.057M
YoY Change
Total Liabilities & Shareholders Equity $6.042M $80.37K $80.37K
YoY Change 2205.85% 702.57% 702.9%

Cashflow Statement

Concept 2023 Q2 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$1.480M -$695.5K -$2.802M
YoY Change 90.79% 331.84% 378.37%
Depreciation, Depletion And Amortization $430.00 $450.00 $1.045K
YoY Change 168.75%
Cash From Operating Activities -$1.228M -$39.65K -$910.9K
YoY Change 100.68% -54.9% 138.2%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $8.744K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 -$8.744K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.268M 55.10K $967.3K
YoY Change 49.34% -15.1% 149.69%
NET CHANGE
Cash From Operating Activities -1.228M -39.65K -$910.9K
Cash From Investing Activities 0.000 0.000 -$8.744K
Cash From Financing Activities 1.268M 55.10K $967.3K
Net Change In Cash 40.05K 15.45K $47.66K
YoY Change -82.47% -167.12% 854.07%
FREE CASH FLOW
Cash From Operating Activities -$1.228M -$39.65K -$910.9K
Capital Expenditures $0.00 $0.00 $8.744K
Free Cash Flow -$1.228M -$39.65K -$919.6K
YoY Change 97.85% 140.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2021 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingExercised
shares
CY2021 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Intrinsic Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingIntrinsicExercised
usd
CY2021 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePriceExercised
CY2021 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingForfeited
shares
CY2021 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Intrinsic Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingIntrinsicForfeited
usd
CY2021 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePriceForfeited
CY2022 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingExercised
shares
CY2022 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Intrinsic Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingIntrinsicExercised
usd
CY2022 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePriceExercised
CY2022 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingForfeited
shares
CY2022 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Intrinsic Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingIntrinsicForfeited
usd
CY2022 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePriceForfeited
CY2022 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingExpired
shares
CY2022 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Intrinsic Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingIntrinsicExpired
usd
CY2022 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePriceExpired
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001829247
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2021 us-gaap Revenues
Revenues
usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2021 us-gaap Gross Profit
GrossProfit
usd
CY2021 us-gaap Salaries And Wages
SalariesAndWages
usd
CY2022 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2021 us-gaap Depreciation
Depreciation
usd
CY2021 BFRG Issuance Of Stock For License
IssuanceOfStockForLicense
usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
CY2022 BFRG Proceeds From Convertible Notes Payable Related Party
ProceedsFromConvertibleNotesPayableRelatedParty
usd
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2022 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021 BFRG Reclassification Of Warrant
ReclassificationOfWarrant
usd
CY2021 BFRG Conversion Of Convertible Note Payable
ConversionOfConvertibleNotePayable
usd
CY2021 BFRG Cancellation Of Common Stock
CancellationOfCommonStock
usd
CY2021 us-gaap Stock Issued1
StockIssued1
usd
CY2022 BFRG Warrants Issued For Convertible Notes
WarrantsIssuedForConvertibleNotes
usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
usd
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-41600
CY2022 dei Entity Registrant Name
EntityRegistrantName
BULLFROG AI HOLDINGS, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-4786155
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
325 Ellington Blvd.
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Unit 317
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Gaithersburg
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20878
CY2022 dei City Area Code
CityAreaCode
(240)
CY2022 dei Local Phone Number
LocalPhoneNumber
658-6710
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6086952 shares
CY2022 dei Auditor Firm
AuditorFirmId
2738
CY2022 dei Auditor Name
AuditorName
M&K CPAS, PLLC
CY2022 dei Auditor Location
AuditorLocation
Houston, Texas
CY2022Q4 us-gaap Cash
Cash
57670 usd
CY2021Q4 us-gaap Cash
Cash
10014 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
72670 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
10014 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7699 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
7699 usd
CY2022Q4 us-gaap Assets
Assets
80369 usd
CY2021Q4 us-gaap Assets
Assets
10014 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
543993 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
68594 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
416072 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
68557 usd
CY2022Q4 BFRG Accrued Liabilities Related Parties Current
AccruedLiabilitiesRelatedPartiesCurrent
566916 usd
CY2021Q4 BFRG Accrued Liabilities Related Parties Current
AccruedLiabilitiesRelatedPartiesCurrent
285666 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
32000 usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10000 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
49000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
12962 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1323890 usd
CY2021Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
284038 usd
CY2022Q4 BFRG Convertible Notes Payable Related Parties Current
ConvertibleNotesPayableRelatedPartiesCurrent
254850 usd
CY2021Q4 BFRG Convertible Notes Payable Related Parties Current
ConvertibleNotesPayableRelatedPartiesCurrent
253266 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3137721 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1019121 usd
CY2022Q4 us-gaap Liabilities
Liabilities
3137721 usd
CY2021Q4 us-gaap Liabilities
Liabilities
1019121 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4021935 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4021935 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4622789 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4622789 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
40 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
46 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1341662 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
587415 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4399055 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1596568 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3057352 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1009107 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3057352 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1009107 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80369 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10014 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10000 usd
CY2022 us-gaap Revenues
Revenues
10000 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
800 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
800 usd
CY2022 us-gaap Gross Profit
GrossProfit
9200 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
609270 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1307882 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
327329 usd
CY2022 us-gaap Salaries And Wages
SalariesAndWages
98250 usd
CY2022 BFRG Payroll And Salary Related Parties
PayrollAndSalaryRelatedParties
449599 usd
CY2021 BFRG Payroll And Salary Related Parties
PayrollAndSalaryRelatedParties
203033 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
2465001 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
555362 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-2455801 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-555362 usd
CY2022 us-gaap Interest Expense
InterestExpense
347145 usd
CY2021 us-gaap Interest Expense
InterestExpense
40395 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
459 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9917 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-346686 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30478 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2802487 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-585840 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.70
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-14
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4009852 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4116336 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-540518 usd
CY2021 BFRG Stockholder Equity Subscriptions Receivable
StockholderEquitySubscriptionsReceivable
100 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
13661 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
4539 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9385 usd
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
89566 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-585840 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1009107 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1009107 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
9221 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
340152 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
226138 usd
CY2022 BFRG Adjustments To Additional Paid In Reclassifications Of Warrant
AdjustmentsToAdditionalPaidInReclassificationsOfWarrant
-11097 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
189828 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2802487 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3057352 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3057352 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2802487 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-585840 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
9917 usd
CY2022 us-gaap Depreciation
Depreciation
1045 usd
CY2022 BFRG Issuance Of Stock For License
IssuanceOfStockForLicense
189828 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
340152 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
98951 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
214429 usd
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
12665 usd
CY2022 BFRG Receivables With Imputed Interest Amount
ReceivablesWithImputedInterestAmount
-9221 usd
CY2021 BFRG Receivables With Imputed Interest Amount
ReceivablesWithImputedInterestAmount
-4539 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
15000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
475399 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-25853 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
373273 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
27384 usd
CY2022 BFRG Increase Decrease In Accrued Expenses Related Parties
IncreaseDecreaseInAccruedExpensesRelatedParties
281250 usd
CY2021 BFRG Increase Decrease In Accrued Expenses Related Parties
IncreaseDecreaseInAccruedExpensesRelatedParties
85666 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
22000 usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
10000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-910890 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-382405 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8744 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8744 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1016290 usd
CY2021 BFRG Proceeds From Convertible Notes Payable Related Party
ProceedsFromConvertibleNotesPayableRelatedParty
298900 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
49000 usd
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
88400 usd
CY2021 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
100 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
967290 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
387400 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
47656 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4995 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10014 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5019 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57670 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10014 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
5757 usd
CY2022 BFRG Reclassification Of Warrant
ReclassificationOfWarrant
11097 usd
CY2022 BFRG Conversion Of Convertible Note Payable
ConversionOfConvertibleNotePayable
226138 usd
CY2022 BFRG Cancellation Of Common Stock
CancellationOfCommonStock
8 usd
CY2022 us-gaap Stock Issued1
StockIssued1
189828 usd
CY2022 BFRG Stock Issued For Services
StockIssuedForServices
340152 usd
CY2021 BFRG Stock Issued For Services
StockIssuedForServices
20 usd
CY2021 BFRG Warrants Issued For Convertible Notes
WarrantsIssuedForConvertibleNotes
13661 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
32000 usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_zYObEEAGQtQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><span style="text-decoration: underline"><span id="xdx_865_z9HjrNDn7Z81">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company’s stock, stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Cash
Cash
57670 usd
CY2021Q4 us-gaap Cash
Cash
10014 usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zXbTSJxUIS08" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><span style="text-decoration: underline"><span id="xdx_86C_zck0c8zsrJBb">Concentrations of Credit Risk</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company’s financial instruments that are exposed to a concentration of credit risk are cash and accounts receivable. Occasionally, the Company’s cash in interest-bearing accounts may exceed FDIC insurance limits. The financial stability of these institutions is periodically reviewed by senior management.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
800 usd
CY2022Q4 BFRG Percentage Of Royalty
PercentageOfRoyalty
0.08 pure
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10000 usd
CY2022Q4 BFRG Shares Exchanged For Each Convertible Preferred Stock
SharesExchangedForEachConvertiblePreferredStock
10 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0301 pure
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
927373 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
753174 shares
CY2020Q2 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
BullFrog AI Holdings, Inc. acquired BullFrog AI, Inc. via a 1:1 share exchange. Immediately prior to the share exchange, each authorized common share of BullFrog AI, Inc. was split into 25 shares of common stock
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
226138 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
189828 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8744 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1045 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7699 usd
CY2022 us-gaap Depreciation
Depreciation
1045 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1526981 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
422817 usd
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4021935 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4622789 shares
CY2022 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-7 reverse stock split
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0126 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0133 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.89 pure
CY2021Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
34000 usd
CY2021Q2 us-gaap Short Term Debt Percentage Bearing Variable Interest Rate
ShortTermDebtPercentageBearingVariableInterestRate
0.05 pure
CY2021Q2 us-gaap Short Term Debt Interest Rate Increase
ShortTermDebtInterestRateIncrease
0.01 pure
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
5000 usd
CY2021Q4 us-gaap Short Term Debt Percentage Bearing Variable Interest Rate
ShortTermDebtPercentageBearingVariableInterestRate
0.05 pure
CY2021Q4 us-gaap Short Term Debt Interest Rate Increase
ShortTermDebtInterestRateIncrease
0.01 pure
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
10000 usd
CY2021Q4 us-gaap Short Term Debt Percentage Bearing Variable Interest Rate
ShortTermDebtPercentageBearingVariableInterestRate
0.05 pure
CY2021Q4 us-gaap Short Term Debt Interest Rate Increase
ShortTermDebtInterestRateIncrease
0.01 pure
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
566916 usd
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
285666 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
90000 usd
CY2021 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
29286 shares
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1803 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
884821 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
29286 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
445536 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
468571 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
399354 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
69217 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
104795 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
12706 usd
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.36
CY2021 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingGranted
1310 shares
CY2021 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Intrinsic Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingIntrinsicGranted
157 usd
CY2021 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePriceGranted
2.66
CY2021 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingExpired
-66524 shares
CY2021 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Intrinsic Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingIntrinsicExpired
-7922 usd
CY2021 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePriceExpired
-3.36
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
39581 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
4941 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.36
CY2022 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingGranted
16661 shares
CY2022 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Intrinsic Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingIntrinsicGranted
2010 usd
CY2022 BFRG Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePriceGranted
2.73
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
56242 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
6951 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.15
CY2022Q4 us-gaap Share Price
SharePrice
4.76
CY2021Q4 us-gaap Share Price
SharePrice
0.308
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0079 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.93 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2022Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
92859 shares
CY2021 BFRG Share Based Compensation Arrangement By Share Based Payment Award Warrants Vested And Expected To Vest Outstanding Intrinsic Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsVestedAndExpectedToVestOutstandingIntrinsicGranted
22208 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
4399055 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
924000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
339000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
924000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
339000 usd

Files In Submission

Name View Source Status
0001493152-23-013524-index-headers.html Edgar Link pending
0001493152-23-013524-index.html Edgar Link pending
0001493152-23-013524.txt Edgar Link pending
0001493152-23-013524-xbrl.zip Edgar Link pending
bfrg-20221231.xsd Edgar Link pending
ex10-10.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_001.jpg Edgar Link pending
form10-k_002.jpg Edgar Link pending
form10-k_003.jpg Edgar Link pending
form10-k_004.jpg Edgar Link pending
form10-k_005.jpg Edgar Link pending
form10-k_006.jpg Edgar Link pending
form10-k_007.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
bfrg-20221231_lab.xml Edgar Link unprocessable
bfrg-20221231_cal.xml Edgar Link unprocessable
bfrg-20221231_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bfrg-20221231_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending